1-3 of 3
Antoine J Boudot
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Trial in Progress: A Phase 1 Umbrella Study of TCR-Engineered T Cells That Target HA-1 (TSC-100) and HA-2 (TSC-101) to Treat Residual Leukemia after Hematopoietic Cell Transplantation

Free
Ran Reshef, Hyung C. Suh, Monzr M. Al Malki, Aasiya Matin, Ashish S Kothari, Allison Bell, Antoine J Boudot, Yun Wang, Nina Abelowitz, James Murray, Gavin Macbeath, Debora Barton, Shrikanta Chattopadhyay
Journal: Blood
Blood (2022) 140 (Supplement 1): 7468–7469.
https://doi.org/10.1182/blood-2022-167707
Published: 2022
Journal Articles

Discovery of TSC-101: A First-in-Class Natural HA-2-Specific TCR to Treat Leukemia Following Hematopoietic Stem Cell Transplant Therapy

Free
Ribhu Nayar, Mollie M Jurewicz, Sonal Jangalwe, Hannah Bader, Kimberly M Cirelli, Andrew Basinski, Daniel Pollacksmith, Alexandra Luther, Cisem Karaca, Anna Labrozzi, Krista Daniel, Lisa Nip, Danielle Ramsdell, Amy Virbasius, Candace Perullo, Kenneth L Jahan, Sida Liao, Livio Dukaj, Alexandra Cristofaro, Shrikanta Chattopadhyay, Kenneth Olivier, Antoine J Boudot, Qikai Xu, Yifan Wang, Cagan Gurer, Gavin Macbeath
Journal: Blood
Blood (2021) 138 (Supplement 1): 1704.
https://doi.org/10.1182/blood-2021-151317
Published: 2021
Journal Articles

Product Characteristics and Multi-Arm Clinical Trial Design for TSC-100 and TSC-101, TCR-T Cells That Target Leukemia Following Hematopoietic Cell Transplantation

Free
Shrikanta Chattopadhyay, Christopher Malcuit, Ryo Takeuchi, Emmett Hedblom, Warren Jaworowicz, Antoine J Boudot, Hannah Bader, James Murray, Gavin Macbeath
Journal: Blood
Blood (2021) 138 (Supplement 1): 3863.
https://doi.org/10.1182/blood-2021-153844
Published: 2021